Company Filing History:
Years Active: 1994-2005
Title: John Gerard Connolly: Pioneering Innovations in Neuronal Acetylcholine Receptors
Introduction
John Gerard Connolly is an accomplished inventor based in Del Mar, California, known for his significant contributions to the field of neuroscience. With a total of four patents, Connolly has advanced our understanding of neuronal nicotinic acetylcholine receptors, which play a crucial role in neurotransmission.
Latest Patents
Connolly's latest patents focus on neuronal nicotinic acetylcholine receptor compositions. These inventions relate to a family of neuronal nicotinic acetylcholine receptors composed of both agonist and non-agonist binding subunits, along with the DNA sequences encoding these subunits. The innovative subunits include agonist binding subunits alpha2, alpha3, alpha4, and alpha5, as well as non-agonist binding subunits beta2, beta3, and beta4. For patent purposes, representative cDNA clones containing the DNA sequences of the invention have been deposited with the American Type Culture Collection.
Career Highlights
John Gerard Connolly is affiliated with the Salk Institute for Biological Studies, a leading research institution dedicated to biological research. Through his work,Connolly has made significant strides in advancing the scientific community's knowledge of neuronal functions and interactions.
Collaborations
Throughout his career, Connolly has collaborated with other notable researchers in the field, including Stephen Fox Heinemann and James Warner Patrick. These partnerships have contributed to the innovation and exploration of new scientific frontiers in neuroscience.
Conclusion
John Gerard Connolly exemplifies the spirit of innovation in the realm of neuroscience. His pioneering patents and collaborative work at the Salk Institute for Biological Studies have laid the groundwork for future discoveries related to neuronal nicotinic acetylcholine receptors, underscoring the importance of his contributions to the field.